Document Detail


Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.
MedLine Citation:
PMID:  23382484     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND Established hypertension is associated with abnormal exercise hemodynamics and reduced exercise capacity through mechanisms that may include contributions from arterial stiffness and endothelial vasomotor dysfunction. Phosphodiesterase type 5 (PDE5) inhibitors prolong nitric oxide-mediated cyclic guanosine monophosphate (cGMP) signaling in vascular smooth muscle, and have beneficial effects on exercise tolerance in pulmonary hypertension and heart failure. Recent studies suggest they may also be useful antihypertensive agents. We hypothesized they would reduce arterial stiffness and increase exercise capacity in hypertensive men. METHODS In a 3-way, randomized, placebo-controlled study, 15 untreated hypertensive and 15 matched normotensive male subjects received 50mg sildenafil (PDE5 inhibitor), 25mg hydralazine (control, cGMP-independent vasodilator) or placebo, 3 times daily for 1 week, and the effects on exercise blood pressure (during modest and maximal exercise), peak oxygen uptake, and arterial stiffness were investigated. RESULTS Peak oxygen uptake was significantly lower in hypertensive than normotensive subjects (analysis of variance [ANOVA] P < 0.0001), but not affected by sildenafil in either group. However, while pulse wave velocity, as a measure of arterial stiffness, increased after exercise in hypertensive men following placebo, sildenafil reversed these changes, significantly reducing pulse wave velocity compared with both placebo and hydralazine (ANOVA P = 0.0001). CONCLUSIONS PDE5 inhibition with sildenafil did not improve exercise capacity in hypertensive men. Nevertheless, our findings suggest that sildenafil may reduce arterial stiffness in the recovery period after exercise.
Authors:
Teresa M Attinà; Iain D Drummond; Lorenzo S Malatino; Simon R Maxwell; David J Webb
Related Documents :
12070214 - Role of the autonomic nervous system in the reduced maximal cardiac output at altitude.
7649924 - Maximal exercise performance in chronic hypoxia and acute normoxia in high-altitude nat...
11417424 - Cardiopulmonary and metabolic responses in healthy elderly humans during a 1-week hikin...
9327114 - Are the laboratory and field conditions observations of acute mountain sickness related?
23864514 - Effect of whole-body vibration exercise on mobility, balance ability and general health...
3316904 - Effect of different post-exercise sugar diets on the rate of muscle glycogen synthesis.
Publication Detail:
Type:  Journal Article     Date:  2013-01-07
Journal Detail:
Title:  American journal of hypertension     Volume:  26     ISSN:  1941-7225     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  342-50     Citation Subset:  IM    
Affiliation:
Clinical Pharmacology Unit, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, UK;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Habitual exercise and blood pressure: age dependency and underlying mechanisms.
Next Document:  Peripheral facial nerve palsy in severe systemic hypertension: a systematic review.